Epiq Capital, a premier growth and late-stage tech investment firm, has announced the final closing of Epiq Capital II, which was oversubscribed at $225 million.
According to a press release, the company will keep investing in exceptional entrepreneurs targeting the $5 trillion digital India opportunity in the next decade. Leading tech entrepreneurs, industrialists, leaders in sports and entertainment, family offices, sovereign wealth funds, and other institutions are among the fund’s domestic and global investors.
Its portfolio includes health-tech firm Pristyncare, leading fitness platform Curefit, local language content platform Dailyhunt, eyewear unicorn Lenskart, and SaaS platform Builder.ai.
According to the investment firm, these companies have an average annualized revenue run rate of over $250 million and have seen a CAGR of over 75% over the last three years.
“We will continue to invest in exceptional entrepreneurs who aspire to build the next Tech Nifty 50. The firm, with its marquee investor base, institutional quality investment team, and exceptional portfolio, is well-positioned as a premier homegrown investing franchise to deliver significant returns to investors,” said Rishi Navani, Founder & Managing Partner, Epiq Capital.
